Skip to main content
. 2013 Aug 8;8(8):e73639. doi: 10.1371/journal.pone.0073639

Figure 2. Median changes in markers of renal tubular function between baseline and 48 weeks.

Figure 2

(A) Urinary β2 microglobulin, (B) Urinary albumin, (C) Percent tubular resorption of phosphate, (D) Urinary N-acetyl-β-D-glucosaminidase. RAL, raltegravir; DRV/r, ritonavir-boosted darunavir; LPV/r, ritonavir-boosted lopinavir; TVD, fixed dose of tenofovir/emtricitabine.